0374 (0374) Fair Value & Analysis

Consumer Defensive · Market cap HK$954M

0 0374 0374 · HK

PriceHK$2.51

Fair ValueHK$0.5600

Upside-77.7%

Quality55/100

Evidence: Medium Range HK$0.4200 – HK$0.7000

Fair value as of: Jul 1, 2026

From 14 valuation models · updated today

Share price +0.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$2.41 – HK$2.72 · fair‑value band HK$0.4200 – HK$0.7000 · the HK$2.51 price screens above the HK$0.5600 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0374 (0374) currently trades at HK$2.51, while our model-based Fair Value estimate is HK$0.5600 — implying the stock looks roughly 77.7% overvalued today. We read business quality at 55/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0374 generated revenue of HK$3.7B at a net margin of 0.1%. Revenue grew 3.2% year over year. It earns a return on equity of 0.1%. Net debt stands at HK$836M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$3.7B

Revenue growth (YoY) +3.2%

Net margin 0.1%

Return on equity 0.1%

Free cash flow −HK$102M FY2025

P/E ratio 83.7

More key figures

Operating margin 2.2%

Dividend yield 3.8%

EPS growth (YoY) -35.4%

Net debt HK$836M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0374 reported revenue of HK$3.6B in FY2025 versus HK$4.6B in FY2021, a compound −5.7%/yr. Reported net income was HK$10.2M in FY2025, compounding −23.8%/yr from FY2021.

Revenue −5.7%/yr

FY21 HK$4.6B

FY22 HK$4.7B

FY23 HK$4.2B

FY24 HK$3.9B

FY25 HK$3.6B

Net income −23.8%/yr

FY21 HK$30.1M

FY22 HK$12.6M

FY23 HK$40.7M

FY24 HK$34.7M

FY25 HK$10.2M

Is 0374 fairly valued? → Check now

Similar stocks

6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Nestlé S.A NESN	CHF 79.73	CHF 55.79	-30%
Foshan Haitian Flavouring and Food Company 603288	¥34.03	¥23.66	-30%
Nestlé India Limited NESTLEIND	₹1,386	₹278.10	-80%
Grupo Bimbo, S.A. BIMBOA	57.10 MXN	45.03 MXN	-21%
Uni-President Enterprises Corp 1216	75.60 TWD	55.53 TWD	-27%
Britannia Industries Limited BRITANNIA	₹5,171	₹1,966	-62%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0374 (0374) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.5600 versus a price of HK$2.51 — about −78% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0374?

Our model-based fair value for 0374 is HK$0.5600 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$2.51.

What is the quality score of 0374?

0374 has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0374 (0374)?

0374 reported trailing-twelve-month revenue of about HK$3.7B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0374?

The net profit margin of 0374 is about 0.1%, meaning it keeps roughly 0.1% of revenue as net income. Based on the latest reported figures.

Does 0374 pay a dividend?

0374 currently shows a dividend yield of about 3.78% relative to its recent price (as of Jul 1, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.